European Heart Journal - My Cardio Interview: Murray Esler & Thomas Luscher on Symplicity HTM-2

submitted by: OxfordJournals

Murray Esler in conversation with Thomas Lüscher
Symplicity HTM-2: International, Multicenter, Prospective, Randomized, Controlled Trial of Endovascular Selective Renal Sympathetic Denervation for the Treatment of Hypertension

European Heart Journal - My Cardio Interview: Ron Peters & Ulf Landmesser on RESPONSE

submitted by: OxfordJournals

Ron Peters in conversation with Ulf Landmesser
RESPONSE: Effect of a nurse coordinated prevention program on cardiovascular risk after an acute coronary syndrome: Main results of the RESPONSE trial.

European Heart Journal - My Cardio Interview: Sanjit Jolly & Thomas Luscher on FUTURA OASIS 8

submitted by: OxfordJournals

Sanjit Jolly in conversation with Thomas Lüscher
FUTURA OASIS 8 : A randomised trial comparing two regimens of adjunctive intravenous unfractionated heparin during PCI in high-risk patients with non-STE-ACS treated with fondaparinux.

European Heart Journal - My Cardio Interview: Jens Nielsen & Thomas Luscher on DANPACE

submitted by: OxfordJournals

Jens Nielsen In conversation with Thomas Lüscher
DANPACE: The Danish multicentre randomised trial on single lead atrial versus dual chamber pacing in sick sinus syndrome.

European Heart Journal - My Cardio Interview: Bernard Gersh & Thomas Luscher on the management of hypertrophic cardiomyopathy

submitted by: OxfordJournals

Bernard Gersh In conversation with Thomas Lüscher
The management of hypertrophic cardiomyopathy: evidence and uncertainties.

European Heart Journal - My Cardio Interview: John McMurray & Frank Ruschitzka on TREAT

submitted by: OxfordJournals

John McMurray In conversation with Frank Ruschitzka
TREAT: Trial to Reduce Cardiovascular Events with Aranesp (darbepoetin) Therapy.

European Heart Journal - My Cardio Interview: Andreas Goette & Bernard Gersh on ANTIPAF

submitted by: OxfordJournals

Andreas Goette In conversation with Bernard Gersh
ANTIPAF: Angiotensin II-antagonist in paroxysmal atrial fibrillation trial.

European Heart Journal - My Cardio Interview: Stephanie Schulz & Ulf Landmesser on ISAR REACT 3A

submitted by: OxfordJournals

Stefanie Schulz in conversation with Ulf Landmesser
ISAR REACT 3A: A trial of reduced dose of unfractionated heparin in patients undergoing percutaneous coronary interventions.

European Heart Journal - My Cardio Interview: Sunil Rao & Thomas Luscher on INNOVATE PCI

submitted by: OxfordJournals

Sunil Rao in conversation with Thomas Lüscher
INNOVATE PCI: A Phase II Safety and Efficacy Study of PRT060128 (Elinogrel), a Novel Intravenous and Oral P2Y12 Inhibtor in Non-Urgent PCI.

European Heart Journal - My Cardio Interview: Stuart Connolly & Thomas Luscher on AVERROES

submitted by: OxfordJournals

Stuart Connolly in conversation with Thomas Lüscher
AVERROES: Apixaban Versus Acetylsalicyclic Acid (ASA) to Prevent Strokes.